Journal of clinical ultrasound : JCU · 2025
Prediction of Transabdominal Ultrasound for Detection of Polycystic Ovary Using Hormonal Profile as Gold Standard.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hassan Mahasin G, Alabdulaziz Lamya, Alsadhan Reham, Alotaibi Anoud, Alghamdi Shooq, Bin Ammar Alhanouf, Alotaibi Taif, Alrajhi Anhar, Alowayshiq Rana, Alduraibi Albatoul
Аннотация
BACKGROUND: Polycystic ovary is a hormonal disorder affecting reproductive women, causing hormonal imbalances and multiple cysts. Transabdominal sonography is a noninvasive method for Polycystic ovary assessment, but its accuracy is debated, necessitating validation with gold standard hormonal profiles.
SIGNIFICANCE OF THE STUDY: In virginal females, transvaginal sonography is prohibited. The findings of this study provide valuable insights into transabdominal sonography prediction of polycystic ovary in those females.
AIM: This research addressed the need to evaluate the correlation of transabdominal sonography findings in the context of polycystic ovary with hormonal profile as the gold standard.
METHODS: This cross-sectional study retrospectively reviewed medical records and data to evaluate the prediction of transabdominal sonography for detecting polycystic ovary using hormonal profile as the gold standard. The researchers analyzed data from a randomly selected sample and compared it to laboratory investigations using a designed data collection sheet.
RESULTS: The analysis revealed significant correlations between certain diagnostic features and the luteinizing hormone to follicle-stimulating hormone ratio. These include right and left ovarian volume (p = 0.012 and 0.007, respectively) and right and left ovarian follicular diameter (p = 0.001 for both ovaries).
CONCLUSION: The study highlights the difficulties in diagnosing polycystic ovary syndrome using Transabdominal sonography and hormonal tests, emphasizing the need for a comprehensive approach that integrates both methods for accurate diagnosis.
SIGNIFICANCE OF THE STUDY: In virginal females, transvaginal sonography is prohibited. The findings of this study provide valuable insights into transabdominal sonography prediction of polycystic ovary in those females.
AIM: This research addressed the need to evaluate the correlation of transabdominal sonography findings in the context of polycystic ovary with hormonal profile as the gold standard.
METHODS: This cross-sectional study retrospectively reviewed medical records and data to evaluate the prediction of transabdominal sonography for detecting polycystic ovary using hormonal profile as the gold standard. The researchers analyzed data from a randomly selected sample and compared it to laboratory investigations using a designed data collection sheet.
RESULTS: The analysis revealed significant correlations between certain diagnostic features and the luteinizing hormone to follicle-stimulating hormone ratio. These include right and left ovarian volume (p = 0.012 and 0.007, respectively) and right and left ovarian follicular diameter (p = 0.001 for both ovaries).
CONCLUSION: The study highlights the difficulties in diagnosing polycystic ovary syndrome using Transabdominal sonography and hormonal tests, emphasizing the need for a comprehensive approach that integrates both methods for accurate diagnosis.